JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Helicobacter pylori Infection and Dietary Factors Act Synergistically to Promote Gastric Cancer
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Helicobacter pylori Infection and Dietary Factors Act Synergistically to Promote Gastric Cancer
Raei, Negin; Behrouz, Bahador; Zahri, Saber; Latifi-Navid, Saeid;
  PDF(new window)
 Abstract
However, the incidence of gastric cancer (GC) has been decreased in past decades; GC is the second cause of cancer related death in the world. Evidence has illustrated that several factors including Helicobacter pylori (H. pylori) infection, host genetics, and environmental factors (smoking and particularly diet) may play a crucial role in gastric carcinogenesis. It has been demonstrated that high consumption of fresh fruits, vegetables, high level of selenium and zinc in drinking water, sufficient iron, and cholesterol protect against GC, while; smoked, pickled, and preserved foods in salt, and nitrites increase the risk of GC. Epidemiological studies have also proved that H. pylori infection and a high salt diet could independently induce atrophic gastritis and intestinal metaplasia. Recently, studies have been demonstrated that dietary factors directly influence H. pylori virulence. The use of appropriate diet could reduce levels of H. pylori colonization or virulence and prevent or delay development of peptic ulcers or gastric carcinoma. This is attractive from a number of perspectives including those of cost, treatment tolerability, and cultural acceptability. This review will describe new insights into the pathogenesis of H. pylori in relation to environmental factors, especially dietary, not only to find the developed means for preventing and treating GC, but also for understanding the role of chronic inflammation in the development of other malignancies.
 Keywords
Helicobacter pylori;dietary factors;gastric cancer;
 Language
English
 Cited by
1.
gastritis and its pre-neoplastic lesions amongst US residents, Alimentary Pharmacology & Therapeutics, 2017, 46, 3, 322  crossref(new windwow)
2.
Gastric cancer: Metabolic and metabolomics perspectives (Review), International Journal of Oncology, 2017, 51, 1, 5  crossref(new windwow)
 References
1.
Akopyants NS, Clifton SW, Kersulyte D, et al (1998). Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol, 28, 37-53.

2.
Amieva MR, Vogelmann R, Covacci A, et al (2003). Disruption of the epithelial apical-junctional complex by Helicobacter pylori cagA. Science, 300, 1430-4. crossref(new window)

3.
Auvinen A, Salonen L, Pekkanen J, et al (2005). Radon and other natural radionuclides in drinking water and risk of stomach cancer: a case-cohort study in Finland. Int J Cancer, 114, 109-13. crossref(new window)

4.
Babaei M, Pourfarzi F, Yazdanbod A, et al (2010). Gastric cancer in Ardabil, Iran-a review and update on cancer registry data. Asian Pac J Cancer Prev, 11, 595-9.

5.
Blaser MJ, Berg DE (2001). Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest, 107, 767-73. crossref(new window)

6.
Boquet P, Ricci V (2012). Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol, 20, 165-74. crossref(new window)

7.
Brenner H, Rothenbacher D, Arndt V (2009). Epidemiology of stomach cancer. Methods Mol Biol, 472, 467-77. crossref(new window)

8.
Camargo MC, Lazcano-Ponce E, Torres J, et al (2004). Determinants of Helicobacter pylori seroprevalence in Mexican adolescents. Helicobacter, 9, 106-14. crossref(new window)

9.
Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process--first american cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40.

10.
Correa P (2013). Gastric cancer: overview. Gastroenterol Clin North Am, 42, 211-7. crossref(new window)

11.
Cover TL, Blanke SR (2005). Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol, 3, 320-32. crossref(new window)

12.
Cover TL, Krishna US, Israel DA, et al (2003). Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res, 63, 951-7.

13.
Cover TL, Peek RM, Jr. (2013). Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes, 4, 482-93. crossref(new window)

14.
D'Elia L, Rossi G, Ippolito R, et al (2012). Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr, 31, 489-98. crossref(new window)

15.
de Martel C, Ferlay J, Franceschi S, et al (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 13, 607-15. crossref(new window)

16.
Derakhshan MH, Malekzadeh R, Watabe H, et al (2008). Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut, 57, 298-305. crossref(new window)

17.
Duell EJ, Travier N, Lujan-Barroso L, et al (2011). Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr, 94, 1266-75. crossref(new window)

18.
Epplein M, Nomura AM, Hankin JH, et al (2008). Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii. Cancer Causes Control, 19, 869-77. crossref(new window)

19.
Epplein M, Zheng W, Li H, et al (2014). Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men. Nutr Cancer, 66, 550-7. crossref(new window)

20.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-403. crossref(new window)

21.
Ferreira RM, Machado JC, Letley D, et al (2012). A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens. J Clin Microbiol, 50, 3983-9. crossref(new window)

22.
Fiedorek SC, Malaty HM, Evans DL, et al (1991). Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics, 88, 578-82.

23.
Franco AT, Israel DA, Washington MK, et al (2005). Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A, 102, 10646-51. crossref(new window)

24.
Gancz H, Jones KR, Merrell DS (2008). Sodium chloride affects Helicobacter pylori growth and gene expression. J Bacteriol, 190, 4100-5. crossref(new window)

25.
Gonzalez CA, Figueiredo C, Lic CB, et al (2011). Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Am J Gastroenterol, 106, 867-74. crossref(new window)

26.
Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, et al (2012). Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up. Int J Cancer, 131, 2910-9. crossref(new window)

27.
Haile RW, John EM, Levine AJ, et al (2012). A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila), 5, 150-63. crossref(new window)

28.
Harrison LE, Zhang ZF, Karpeh MS, et al (1997). The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer, 80, 1021-8. crossref(new window)

29.
Hennig EE, Mernaugh R, Edl J, et al (2004). Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA. Infect Immun, 72, 3429-35. crossref(new window)

30.
Higashi H, Tsutsumi R, Muto S, et al (2002). SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori cagA protein. Science, 295, 683-6. crossref(new window)

31.
Honarmand-Jahromy S, Siavoshi F, Malekzadeh R, et al (2015). Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases. World J Gastroenterol, 21, 9317-27. crossref(new window)

32.
Ioannou GN, Rockey DC, Bryson CL, et al (2002). Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med, 113, 276-80. crossref(new window)

33.
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. crossref(new window)

34.
Jenab M, Riboli E, Ferrari P, et al (2006). Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis, 27, 2250-7. crossref(new window)

35.
Joossens JV, Hill MJ, Elliott P, et al (1996). Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol, 25, 494-504. crossref(new window)

36.
Kim HJ, Lim SY, Lee JS, et al (2010). Fresh and pickled vegetable consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci, 101, 508-16. crossref(new window)

37.
Knekt P, Reunanen A, Takkunen H, et al (1994). Body iron stores and risk of cancer. Int J Cancer, 56, 379-82. crossref(new window)

38.
Ladeiras-Lopes R, Pereira AK, Nogueira A, et al (2008). Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control, 19, 689-701. crossref(new window)

39.
Loh JT, Friedman DB, Piazuelo MB, et al (2012). Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of cagA expression. Infect Immun, 80, 3094-106. crossref(new window)

40.
Matsuhisa TM, Yamada NY, Kato SK, et al (2003). Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects. Helicobacter, 8, 29-35. crossref(new window)

41.
Megraud F (2001). Impact of Helicobacter pylori virulence on the outcome of gastroduodenal diseases: lessons from the microbiologist. Dig Dis, 19, 99-103. crossref(new window)

42.
Moy KA, Fan Y, Wang R, et al (2010). Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev, 19, 2287-97. crossref(new window)

43.
Murata-Kamiya N, Kurashima Y, Teishikata Y, et al (2007). Helicobacter pylori cagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene, 26, 4617-26. crossref(new window)

44.
Nakaji S, Fukuda S, Sakamoto J, et al (2001). Relationship between mineral and trace element concentrations in drinking water and gastric cancer mortality in Japan. Nutr Cancer, 40, 99-102. crossref(new window)

45.
Ogiwara H, Sugimoto M, Ohno T, et al (2009). Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol, 47, 3493-500. crossref(new window)

46.
Pourfarzi F, Whelan A, Kaldor J, et al (2009). The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer, 125, 1953-60. crossref(new window)

47.
Pra D, Rech Franke SI, Pegas Henriques JA, et al (2009). A possible link between iron deficiency and gastrointestinal carcinogenesis. Nutr Cancer, 61, 415-26. crossref(new window)

48.
Ren JS, Kamangar F, Forman D, et al (2012). Pickled food and risk of gastric cancer--a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev, 21, 905-15. crossref(new window)

49.
Rhead JL, Letley DP, Mohammadi M, et al (2007). A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterol, 133, 926-36. crossref(new window)

50.
Shaffer CL, Gaddy JA, Loh JT, et al (2011). Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog, 7, 1002237. crossref(new window)

51.
Shikata K, Doi Y, Yonemoto K, et al (2008). Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol, 168, 1409-15. crossref(new window)

52.
Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al (2012). Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet, 380, 1840-50. crossref(new window)

53.
Sonnenberg A (2010). Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut, 59, 736-43. crossref(new window)

54.
Suzuki R, Shiota S, Yamaoka Y (2012). Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol, 12, 203-13. crossref(new window)

55.
Torres VJ, VanCompernolle SE, Sundrud MS, et al (2007). Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol, 179, 5433-40. crossref(new window)

56.
Tramacere I, Negri E, Pelucchi C, et al (2012). A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol, 23, 28-36. crossref(new window)

57.
Tsugane S, Sasazuki S (2007). Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer, 10, 75-83. crossref(new window)

58.
Tyas SL, Pederson LL (1998). Psychosocial factors related to adolescent smoking: a critical review of the literature. Tob Control, 7, 409-20. crossref(new window)

59.
van Lee L, Heyworth J, McNaughton S, et al (2011). Selected dietary micronutrients and the risk of right- and left-sided colorectal cancers: a case-control study in Western Australia. Ann Epidemiol, 21, 170-7. crossref(new window)

60.
Wang XQ, Terry PD, Yan H (2009). Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol, 15, 2204-13. crossref(new window)

61.
Waring AJ, Drake IM, Schorah CJ, et al (1996). Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut, 38, 171-6. crossref(new window)

62.
Winter JA, Letley DP, Cook KW, et al (2014). A role for the vacuolating cytotoxin, VacA, in colonization and Helicobacter pylori-induced metaplasia in the stomach. J Infect Dis, 210, 954-63. crossref(new window)

63.
Wiseman M (2008). The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc, 67, 253-6. crossref(new window)

64.
Woodward M, Morrison C, McColl K (2000). An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol, 53, 175-81. crossref(new window)

65.
Wu X, Chen VW, Andrews PA, et al (2007). Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control, 18, 585-93. crossref(new window)

66.
Wunder C, Churin Y, Winau F, et al (2006). Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med, 12, 1030-8. crossref(new window)

67.
Yamaguchi N, Kakizoe T (2001). Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol, 2, 88-94. crossref(new window)

68.
Yip R, Limburg PJ, Ahlquist DA, et al (1997). Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA, 277, 1135-9. crossref(new window)

69.
You WC, Blot WJ, Chang YS, et al (1988). Diet and high risk of stomach cancer in Shandong, China. Cancer Res, 48, 3518-23.